Ventilator-associated pneumonia

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Respiratory Medicine

Background:

• Ventilator-associated pneumonia (VAP) is a common nosocomial infection.
• It develops more than 48 hours after initiating tracheal intubation and mechanical ventilation.
• Respiratory tract contamination, particularly silent aspiration, is a primary infection route.

Purpose of the Study:

• To outline the pathogenesis and transmission routes of VAP.
• To discuss diagnostic strategies for identifying causative pathogens.
• To review effective prevention and treatment approaches for VAP.

Main Methods:

• Review of current literature on VAP pathogenesis and management.
• Emphasis on infection control measures, including endotracheal tube suctioning.
• Discussion of diagnostic methods, from direct specimen collection to clinical assessment and tracheal aspirate cultures.

Main Results:

• Silent aspiration of oropharyngeal secretions is a key VAP transmission route.
• Suctioning secretions above the endotracheal tube cuff is an effective preventive measure.
• Diagnosis can be achieved through direct specimen analysis or clinical evaluation with tracheal aspirate cultures.

Conclusions:

• Implementing appropriate infection control measures, such as meticulous circuit management and suctioning, is crucial for VAP prevention.
• While direct specimen collection is ideal, clinical diagnosis and tracheal aspirate cultures are practical alternatives.
• Prophylactic antimicrobials are not recommended; treatment should be initiated only after a confirmed diagnosis to target the causative microorganism.